Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer.
Camorani S, Passariello M, Agnello L, Esposito S, Collina F, Cantile M, Di Bonito M, Ulasov IV, Fedele M, Zannetti A, De Lorenzo C, Cerchia L.
Camorani S, et al.
J Exp Clin Cancer Res. 2020 Sep 7;39(1):180. doi: 10.1186/s13046-020-01694-9.
J Exp Clin Cancer Res. 2020.
PMID: 32892748
Free PMC article.